Peregrine Ventures

About

Portfolio · 56

Snipe Medical

A Novel Solution to Treat Lung Cancer

Led ★ 4 rounds $2.0M committed Latest: 2026-02

Ionara Bio

Stealth Mode Startup

Led ★ 2 rounds $800K committed Latest: 2026-01

Bio Refine

Endovascular Annuloplasty Remodeling System

2 rounds $900K committed Latest: 2025-10

Aluma Endovascular Systems

Advanced Laser Energy Delivery Systems With Proprietary Fiber Technology Integrated Into Catheters

2 rounds Latest: 2025-10

Raziel Therapeutics

Injectable Drug for Treatment of Obesity

2 rounds Latest: 2025-10

Cordio Medical

Medical Speech-processing Platform

5 rounds $18.4M committed Latest: 2025-10

Terrapeutics Pharma

Drug Discovery Platform focused on soil bacteria producing drugs to tackle undruggable targets.

3 rounds $2.5M committed Latest: 2025-10

KAHR Medical

Fusion Proteins for Treating Cancer and Autoimmune Diseases

5 rounds $64.8M committed Latest: 2025-09

EviCure

Extracellular Vesicles-based Platform for the Treatment of Cancer

Led ★ 3 rounds $700K committed Latest: 2025-09

Endomatic

Endovascular Left Atrial Appendage Closure Device

Led ★ 4 rounds $1.0M committed Latest: 2025-08

Focal Medical Technology

Minimally Invasive System for Mapping and Focal Ablation of Prostate Cancer

Led ★ 4 rounds $830K committed Latest: 2025-08

Restore Medical

Catheter-delivered Implant for Congestive Heart Failure

4 rounds $26.8M committed Latest: 2025-07

EndoPulse

Life-saving Cardiac Support Device

1 round Latest: 2025-05

Variantyx

Advanced Genomic Diagnostic Solutions

4 rounds $77.5M committed Latest: 2025-04

Aleph Farms

Cellular Agriculture Technology

5 rounds $147.3M committed Latest: 2025-03

DairyX

Yeast Milk Proteins

3 rounds $1.4M committed Latest: 2025-02

Xerient

Next Generation Treatment of Pancreatic Cancer

Led ★ 2 rounds $2.1M committed Latest: 2025-02

Lutris Pharma

Anticancer Therapy for Patients Treated with EGFR Inhibitors

1 round $30.0M committed Latest: 2025-01

Magneto Thrombectomy Solutions

Thrombectomy Solutions

3 rounds $1.9M committed Latest: 2024-10

Insightec

MR-guided Focused Ultrasound Systems

1 round $150.0M committed Latest: 2024-06

Life Therapeutics

Precision Immunotherapies Targeting Circulating Tumor Cells

Led ★ 1 round Latest: 2024-03

Althea Medical

Minimally Invasive Catheter-based Solution

3 rounds $1.4M committed Latest: 2024-01

Bluewhite

AI-powered autonomous solutions for off-road applications in agriculture, defense, and industrial sectors.

3 rounds $86.0M committed Latest: 2024-01

Magnisity

Surgical Guidance Platform

Led ★ 2 rounds $6.3M committed Latest: 2024-01

Trojan Bio

Therapeutic Antibodies for the Treatment of Cancer

1 round Latest: 2023-12

Conair Medical

Implant-Based Solutions

Led ★ 1 round $730K committed Latest: 2023-11

Hairstetics

Nonsurgical Hair Restoration System

Led ★ 3 rounds $1.7M committed Latest: 2023-11

Dokka

Accounting and Bookkeeping Automation Platform

2 rounds $750K committed Latest: 2023-11

Wanda Fish

Sustainable Cell-cultured Fish Meat

2 rounds $10.0M committed Latest: 2023-10

BioProtect

Developer of a biodegradable balloon implant for prostate cancer radiation therapy.

2 rounds $53.0M committed Latest: 2023-09

AnserBio

Nanoparticle based delivery of p53 protein - addressing the most frequent mutation in cancer. -

2 rounds $1.4M committed Latest: 2023-07

Kanso Diagnostics

Molecular Testing Platform

Led ★ 1 round $1.5M committed Latest: 2023-06

W Endoluminal Robotics

Early Diagnosis and Treatment of Lung Cancer

Led ★ 2 rounds $260K committed Latest: 2023-05

OncoRedox

Point-of-care Testing Device for Cancer Detection

Led ★ 1 round $890K committed Latest: 2023-02

Momentis Surgical

Robot-assisted Surgical Platform

3 rounds $24.4M committed Latest: 2023-01

Nectin Therapeutics

Next-generation Immunotherapy Agents

Led ★ 1 round $13.6M committed Latest: 2022-12

Levation Pharma

Topical Oxymetazoline for Cosmetic Eye Lifts

Led ★ 1 round $1.9M committed Latest: 2022-06

Digma Medical

Noninvasive Procedure for Diabetes Treatment

3 rounds $360K committed Latest: 2022-05

BRAIN.Q

Restorative Brain Health Therapeutics to Reverse Disability After Neurological Disease

1 round $39.0M committed Latest: 2021-08

OutSense Diagnostics

Toilet-based IoT Sensor for Detecting GI Conditions

Led ★ 1 round $2.2M committed Latest: 2020-11

Cardiovalve

Cardiovascular Replacement Devices for Minimally Invasive Surgery

2 rounds $45.5M committed Latest: 2020-08

CureSign

Monitoring Cancer Treatment Efficacy

1 round Latest: 2020-02

EndoStream Medical

Aneurysm Devices

1 round $1.9M committed Latest: 2020-01

CartiHeal

Cell-free Cartilage Regeneration

2 rounds $36.0M committed Latest: 2017-05

NitiNotes

Robotic Endoscopic Suturing

1 round $6.4M committed Latest: 2017-03

Rise.ai

Gifting for Online Stores

1 round $454K committed Latest: 2016-11

MarketYze

Price and Inventory Optimization Solutions

1 round $1.1M committed Latest: 2012-10

Eximo Medical

Hybrid Catheters for Interventional Procedures

1 round $921K committed Latest: 2012-10

Quicklizard

AI-based Pricing Optimization Software for Retailers

1 round $150K committed Latest: 2010-01

Rocketick

Software-based Acceleration Solutions

1 round $760K committed Latest: 2009-08

Otic Pharma

Foam-based Products for the Treatment of Ear, Nose, and Throat Disorders

Led ★ 1 round $296K committed Latest: 2009-06

Neovasc

Medical Device Company

1 round $1.9M committed Latest: 2008-06

Eurikify

Identity Management Solutions

1 round $390K committed Latest: 2008-03

Valtech Cardio

Mitral Valve Repair Implants

1 round $1.9M committed Latest: 2006-09

Kailight Photonics

Developer of Optical Modules

1 round $4.5M committed Latest: 2006-01

VisionSense

Stereoscopic Sight for Minimally Invasive Surgery

1 round Latest: 2004-09

Investment activity

17 portfolio exits on record.

Funds · 6

• Peregrine III Annex Fund — $30M Jan 2021
• Peregrine Growth Fund — $180.18M Jun 2020
• Peregrine Fund IV — $115M Dec 2019
• Peregrine Fund III — $75M Apr 2015
• Peregrine Fund II — $27M Sep 2008
• Peregrine Fund I — $15M Apr 2001

Q&A

What is Peregrine Ventures' primary investment focus?

Peregrine Ventures is an Israeli healthcare fund, primarily focusing on the Health Tech & Life Sciences sector, which accounts for 47 of its portfolio companies.

What was a recent notable exit for Peregrine Ventures?

In January 2026, Peregrine Ventures saw BioProtect acquired by Almeda Ventures for $200 million.

Can you name another recent exit for Peregrine Ventures?

In January 2025, Peregrine Ventures had an exit with EndoStream Medical, which was acquired by Kaneka Corporation for $100 million.

Which funds has Peregrine Ventures raised recently?

Peregrine Ventures raised the Peregrine III Annex Fund for $30 million in January 2021 and the Peregrine Growth Fund for $180.18 million in June 2020.

What is Peregrine Ventures' investment stage preference?

Peregrine Ventures invests across various stages including Pre-Seed, Seed, A Round, B Round, C Round, D Round, and E Round.

Who are the co-founders of Peregrine Ventures?

The co-founders and Managing General Partners of Peregrine Ventures are Boaz Lifschitz and Eyal Lifschitz.

What is Peregrine Ventures' most significant portfolio company by funding raised?

Insightec, a company developing MR-guided Focused Ultrasound Systems, has raised $592.9 million, making it one of Peregrine Ventures' most significantly funded portfolio companies.

How many investment rounds has Peregrine Ventures participated in within the last year?

In 2025, Peregrine Ventures participated in 19 investment rounds, and in 2024, they participated in 12 investment rounds.